979TiP POPPY: A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients with performance status 2 with recurrent or metastatic squamous cell carcinoma of the head and neck.
Saved in:
| Title: | 979TiP POPPY: A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients with performance status 2 with recurrent or metastatic squamous cell carcinoma of the head and neck. |
|---|---|
| Authors: | Forsyth, S.1 (AUTHOR), Yip, K.2 (AUTHOR), Foran, B.3 (AUTHOR), Gougis, P.4 (AUTHOR), Wheeler, G.1 (AUTHOR), White, L.1 (AUTHOR), Chandrakumar, A.1 (AUTHOR), Blair, K.5 (AUTHOR), Pathak, Y.6 (AUTHOR), Spanswick, V.6 (AUTHOR), Lowe, H.6 (AUTHOR), Hartley, J.6 (AUTHOR), Forster, M.7 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS686-S687. 2p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
